Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
about
Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical CarcinomaOutcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma.Minimally Invasive Adrenalectomy for Adrenocortical Carcinoma: Five-Year Trends and Predictors of Conversion.Prognostic Factors of Adrenocortical Carcinoma: An Analysis of the Surveillance Epidemiology and End Results (SEER) Database[Surgical strategies for non-metastatic adrenocortical carcinoma].
P2860
Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
@en
type
label
Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
@en
prefLabel
Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
@en
P2093
P2860
P1476
Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm
@en
P2093
Andrew Weaver
Greg Sadler
Parameswaran Rajeev
Tarek Ezzat Abdel-Aziz
P2860
P2888
P304
P356
10.1007/S00268-014-2912-5
P50
P577
2015-05-01T00:00:00Z
P6179
1005759968